| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2022 | Jul 19, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 5.0 | -46,034 | -32.62% | ✓ | $1.4M |
| Jul 13, 2022 | Jul 15, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 45.0 | -1,916 | -1.97% | ✓ | $57.5K |
| May 11, 2022 | May 13, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 32.5 | -5,300 | -5.82% | ✓ | $222K |
| Apr 11, 2022 | Apr 13, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -5,300 | -5.82% | ✓ | $332.7K |
| Apr 4, 2022 | Apr 6, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -7,950 | -8.49% | ✓ | $477K |
| Mar 11, 2022 | Mar 15, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -2,650 | -3.00% | ✓ | $141.4K |
| Feb 11, 2022 | Feb 15, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -2,650 | -3.00% | ✓ | $138K |
| Jan 11, 2022 | Jan 13, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -2,650 | -3.00% | ✓ | $142.4K |
| Jan 5, 2022 | Jan 7, 2022 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -2,650 | -3.00% | ✓ | $159K |
| Dec 13, 2021 | Dec 15, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 47.5 | -2,650 | -0.77% | ✓ | $133.6K |
| Nov 10, 2021 | Nov 12, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 27.5 | -21,200 | -7.49% | ✓ | $1.3M |
| Nov 4, 2021 | Nov 5, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 22.5 | -10,600 | -11.01% | ✓ | $530K |
| Jun 11, 2021 | Jun 15, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 37.5 | -2,650 | -3.29% | ✓ | $135.1K |
| May 11, 2021 | May 13, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 37.5 | -2,650 | -3.59% | ✓ | $132.5K |
| Apr 12, 2021 | Apr 14, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 30.0 | -5,300 | -6.93% | ✓ | $318K |
| Mar 11, 2021 | Mar 15, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -5,300 | -7.97% | ✓ | $341.7K |
| Feb 11, 2021 | Feb 16, 2021 | Keros Therapeutics, Inc. | Chief Scientific Officer | Sell | 17.5 | -5,300 | -15.92% | ✓ | $344K |